Giordano Caponigro

Giordano Caponigro

UNVERIFIED PROFILE

Are you Giordano Caponigro?   Register this Author

Register author
Giordano Caponigro

Giordano Caponigro

Publications by authors named "Giordano Caponigro"

Are you Giordano Caponigro?   Register this Author

24Publications

917Reads

8Profile Views

BRAF-inhibitor Associated MEK Mutations Increase RAF-Dependent and -Independent Enzymatic Activity.

Mol Cancer Res 2017 10 27;15(10):1431-1444. Epub 2017 Jun 27.

Oncology Disease Area, Novartis Institutes for Biomedical Research, Cambridge, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1541-7786.MCR-17-0211DOI Listing
October 2017

Preclinical Therapeutic Synergy of MEK1/2 and CDK4/6 Inhibition in Neuroblastoma.

Clin Cancer Res 2017 Apr 11;23(7):1785-1796. Epub 2016 Oct 11.

Division of Oncology and Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-16-1131DOI Listing
April 2017

Dual CDK4/CDK6 inhibition induces cell-cycle arrest and senescence in neuroblastoma.

Clin Cancer Res 2013 Nov 17;19(22):6173-82. Epub 2013 Sep 17.

Authors' Affiliations: Division of Oncology and Center for Childhood Cancer Research; Division of Pathology, Children's Hospital of Philadelphia; Department of Pediatrics; Abramson Family Cancer Research Institute, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania; and Novartis Institutes for Biomedical Research, Cambridge, Massachusetts.

View Article

Download full-text PDF

Source
http://clincancerres.aacrjournals.org/cgi/doi/10.1158/1078-0
Publisher Site
http://dx.doi.org/10.1158/1078-0432.CCR-13-1675DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3844928PMC
November 2013

Advances in the preclinical testing of cancer therapeutic hypotheses.

Nat Rev Drug Discov 2011 03;10(3):179-87

Novartis Institutes For BioMedical Research, Oncology Research and Oncology Translational Medicine, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrd3385DOI Listing
March 2011

Single-vector inducible lentiviral RNAi system for oncology target validation.

Cell Cycle 2009 Feb 25;8(3):498-504. Epub 2009 Feb 25.

Oncology Research, Novartis Institutes for BioMedical Research, Cambridge, Massachusetts 02139, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4161/cc.8.3.7701DOI Listing
February 2009

Functional analysis of expressed peptides that bind yeast STE proteins.

J Biotechnol 2003 Aug;103(3):213-25

677 7th Ave., Salt Lake City, UT 84103, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0168-1656(03)00127-5DOI Listing
August 2003

Expression levels of transdominant peptides and proteins in Saccharomyces cerevisiae.

Yeast 2002 Jan;19(1):1-7

Deltagen Proteomics, Inc., 615 Arapeen Drive, Suite 300, Salt Lake City, UT 84108, USA.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/yea.795
Publisher Site
http://dx.doi.org/10.1002/yea.795DOI Listing
January 2002